MedPath

Safety and Efficacy Study of the Venous Window Needle Guide to Access Arteriovenous (AV)Fistulae

Phase 2
Completed
Conditions
Kidney Failure
AV Fistula
End Stage Renal Disease
Interventions
Device: Venous Window Needle Guide
Registration Number
NCT01471041
Lead Sponsor
Vital Access Corp.
Brief Summary

The SAVE Study will evaluate the safety and efficacy of the Venous Window Needle Guide in achieving access of a deep, un-cannulatable arteriovenous fistula to complete hemodialysis as prescribed.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
54
Inclusion Criteria
  • Deep, uncannulatable, upper extremity arteriovenous fistula
  • Minimum arteriovenous fistula flow 400 ml/min
  • One year life expectancy
Exclusion Criteria
  • Non-transposed basilic or brachial vein arteriovenous fistula
  • History of peripheral vascular disease
  • History of cardiovascular disease
  • History of cerebral vascular disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Venous Window Needle GuideVenous Window Needle GuideVenous Window Needle Guide will be implanted onto deep, un-cannulatable arteriovenous fistula
Primary Outcome Measures
NameTimeMethod
Use of Venous Window Needle Guide to Obtain Arteriovenous Access for Hemodialysis3 months

Successful cannulation of arteriovenous fistula through the VWNG device and successful hemodialysis achieved within 3 months from index procedure.

Secondary Outcome Measures
NameTimeMethod
Arteriovenous Fistula Cannulation Complications While Using the Venous Window Needle Guide6 months

Frequency of complications occuring when cannulating the arteriovenous fistula through the Venous Window Needle Guide

Trial Locations

Locations (2)

Ladenheim Dialysis Access Centers

🇺🇸

Fresno, California, United States

University of Oklahoma - Tulsa

🇺🇸

Tulsa, Oklahoma, United States

© Copyright 2025. All Rights Reserved by MedPath